Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Accenture
Daiichi Sankyo
Healthtrust
Harvard Business School
Julphar
Colorcon
US Department of Justice
Cerilliant

Generated: November 14, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Momelotinib

« Back to Dashboard

US Patents for Momelotinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Momelotinib ➤ Sign Up Phenyl amino pyrimidine compounds and uses thereof YM Biosciences Australia Pty Ltd (Melbourne, Victoria, AU) ➤ Sign Up
Momelotinib ➤ Sign Up Use of a PKC inhibitor Novartis AG (Basel, CH) ➤ Sign Up
Momelotinib ➤ Sign Up Aryl benzylamine compounds Novartis AG (Basel, CH) ➤ Sign Up
Momelotinib ➤ Sign Up Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections EMORY UNIVERSITY (Atlanta, GA) ➤ Sign Up
Momelotinib ➤ Sign Up Phenyl amino pyrimidine compounds and uses thereof YM BIOSCIENCES AUSTRALIA PTY LTD (Foster City, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Momelotinib

Drugname Country Document Number Estimated Expiration Related US Patent
Momelotinib Australia 2008226327 2027-03-12 ➤ Sign Up
Momelotinib Brazil PI0808888 2027-03-12 ➤ Sign Up
Momelotinib Canada 2702650 2027-03-12 ➤ Sign Up
Momelotinib China 101861313 2027-03-12 ➤ Sign Up
Momelotinib China 104030990 2027-03-12 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Chubb
Boehringer Ingelheim
Colorcon
US Department of Justice
Baxter
Fish and Richardson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.